US stock futures rose Wednesday as the U.S. and Japan reached a trade agreement and Wall Street looked ahead to earnings reports later in the session from Tesla and Alphabet.

These stocks were poised to make moves Wednesday:

Tesla was up 0.2% in premarket trading ahead of second-quarter earnings from the maker of electric vehicles. Wall Street expects Tesla to post an operating profit of $1.1 billion, and earnings of 39 cents a share on sales of $22.1 billion. A year earlier, Tesla reported an operating profit of $1.6 billion and earnings of 52 cents a share on sales of $25.5 billion. Coming into the report, Tesla has risen three of the past five days but has declined nearly 18% this year, according to Dow Jones Market Data.

Alphabet gained 0.2% ahead of its quarterly earnings report. Two issues related to artificial intelligence will be under the microscope when the parent of Google reports: Google's heavy data center investments and the performance of its search business, which is under attack for the first time in years. Alphabet has closed higher for 10 straight sessions, rising 9.7% over the span.

Texas Instruments reported second-quarter earnings and revenue that beat analysts' estimates but shares of the semiconductor company were declining 11.7% after it issued a disappointing earnings forecast for the third quarter. The company expects third-quarter earnings of $1.36 to $1.60 a share, which at the midpoint was below Wall Street consensus of $1.51. Texas Instruments said the auto market has yet to recover and the risk from new tariffs in the future wasn't over.

Second-quarter operating profit and revenue at SAP rose from a year earlier and the German enterprise software maker backed its previous full-year guidance. Shares listed in the U.S., however, were down 3.8% in premarket trading. Cloud revenue in the second quarter rose 24% to EUR5.13 billion but missed estimates of EUR5.18 billion.

Capital One Financial reported a second-quarter loss following its acquisition of Discover Financial Services in May, but adjusted earnings in the period of $5.48 a share topped analysts' forecasts of $4.03. Shares rose 4%.

Enphase Energy was down 6.9% after the maker of solar-power inverters topped earnings and revenue estimates in the second quarter but said it anticipates third-quarter revenue of $330 million to $370 million versus consensus of $368.5 million.

Kohl's was down 2% after closing with a gain Tuesday of 38%, the stock's largest daily percentage increase on record, according to Dow Jones Market Data. The stock rose as much as 105% in Tuesday's session as the level of short interest in Kohl's -- at nearly 50% -- caught the attention of retail traders, making the discount retailer the stock market's newest meme stock.

GoPro soared 47.5% and Beyond Meat surged 13.5% as meme stocks are back and retail is about to get burned again.

Usana Health Sciences rose 17% after the maker of nutritional and weight-management products reported second-quarter adjusted earnings rose to 74 cents a share from 54 cents a year earlier as revenue jumped 11% to $236 million.

Cal-Maine Foods was rising 5.1% after reporting a large jump in fiscal fourth-quarter earnings and revenue that soared 72% to $1.1 billion as the egg producer and distributor said its net average selling price per dozen eggs increased 55% to $3.31 and it sold 311.4 million dozen shell eggs, up 9% from a year earlier.

In addition to reports from Tesla and Alphabet, earnings reports are expected Wednesday from International Business Machines, AT&T, T-Mobile, ServiceNow, GE Vernova, NextEra Energy, General Dynamics, O'Reilly Automotive, Chipotle Mexican Grill, and CSX.

AT&T was down 0.8% in premarket trading. Wall Street expects the telecommunications company to post adjusted earnings in the second quarter of 53 cents a share on revenue of $30.46 billion. A focus for investors will be on postpaid wireless subscribers. When Verizon Communications posted quarterly earnings on Monday, it said it lost 9,000 across its consumer and business divisions, when analysts were looking for 13,000 additions.

U.S.-Listed Shares of Abivax soared 414% in premarket trading after positive late-stage study results for its bowel disease treatment.